Probiotics intervention for type 2 diabetes mellitus therapy: a review from proposed mechanisms to future prospects

被引:0
作者
Li, Xue [1 ,2 ]
Xia, Yongjun [1 ,2 ]
Song, Xin [1 ,2 ]
Xiong, Zhiqiang [1 ,2 ]
Ai, Lianzhong [1 ,2 ]
Wang, Guangqiang [1 ,2 ]
机构
[1] Univ Shanghai Sci & Technol, Sch Hlth Sci & Engn, Shanghai, Peoples R China
[2] Univ Shanghai Sci & Technol, Shanghai Engn Res Ctr Food Microbiol, Shanghai, Peoples R China
基金
美国国家科学基金会;
关键词
T2DM; probiotics; proposed mechanisms; future prospects; HIGH-FAT DIET; CHAIN AMINO-ACIDS; GLYCEMIC CONTROL; GUT MICROBIOTA; INSULIN-RESISTANCE; SIGNALING PATHWAY; GLUCOSE-TOLERANCE; METABOLISM; SECRETION; OBESITY;
D O I
10.1080/10408398.2024.2387765
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Type 2 diabetes mellitus (T2DM) is one of the metabolic diseases with the highest morbidity rates in the world. Probiotics have positive health impacts on human health and a considerable amount of research has demonstrated their beneficial effects in treating T2DM. However, probiotic intervention in T2DM has complex mechanisms because the pathogenesis of T2DM is complex. This review summarized the mechanisms of probiotic intervention in diabetes from the perspective of diabetes pathogenesis. First, the objectives of probiotic intervention in diabetes aimed at the intestinal tract reparative effects, pancreatic function, host metabolism and self-recovery were comprehensively reviewed. Next, we concluded the clinical application status of ingested probiotics in patients with T2DM, and an obvious imbalance exists between theoretical probiotic research and clinical applications. Finally, we summarized the emerging research on probiotic interventions in T2DM and analyzed the literature in this regard, including next-generation probiotics; suggestions for probiotics consumption with the aim of diabetic complications; as well as the association between novel mechanisms of diabetes remission with the potential for probiotic intervention. In conclusion, this review sheds light on the potential role of probiotics, from proposed mechanisms to prospects in relieving T2DM.
引用
收藏
页数:19
相关论文
共 174 条
  • [1] Retinoic Acid, Leaky Gut, and Autoimmune Diseases
    Abdelhamid, Leila
    Luo, Xin M.
    [J]. NUTRIENTS, 2018, 10 (08)
  • [3] [Anonymous], Diabetes around the world in 2021-2022 [Online] Disponivel em
  • [4] Immune System Stimulation by Probiotic Microorganisms
    Ashraf, Rabia
    Shah, Nagendra P.
    [J]. CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION, 2014, 54 (07) : 938 - 956
  • [5] Improvement in glucose tolerance and insulin sensitivity by probiotic strains of Indian gut origin in high-fat diet-fed C57BL/6J mice
    Balakumar, Mahalingam
    Prabhu, Durai
    Sathishkumar, Chandrakumar
    Prabu, Paramasivam
    Rokana, Namita
    Kumar, Ramesh
    Raghavan, Srividhya
    Soundarajan, Avinash
    Grover, Sunita
    Batish, Virender Kumar
    Mohan, Viswanathan
    Balasubramanyam, Muthuswamy
    [J]. EUROPEAN JOURNAL OF NUTRITION, 2018, 57 (01) : 279 - 295
  • [6] Advancements in the Pharmaceutical Applications of Probiotics: Dosage Forms and Formulation Technology
    Baral, Kshitis Chandra
    Bajracharya, Rajiv
    Lee, Sang Hoon
    Han, Hyo-Kyung
    [J]. INTERNATIONAL JOURNAL OF NANOMEDICINE, 2021, 16 : 7535 - 7556
  • [7] Measuring key human carbohydrate digestive enzyme activities using high-performance anion-exchange chromatography with pulsed amperometric detection
    Barber, Elizabeth
    Houghton, Michael J.
    Visvanathan, Rizliya
    Williamson, Gary
    [J]. NATURE PROTOCOLS, 2022, 17 (12) : 2882 - 2919
  • [8] Probiotics and synbiotics for glycemic control in diabetes: A systematic review and meta-analysis of randomized controlled trials
    Baroni, Irene
    Fabrizi, Diletta
    Luciani, Michela
    Magon, Arianna
    Conte, Gianluca
    De Angeli, Giada
    Paglione, Giulia
    Ausili, Davide
    Caruso, Rosario
    [J]. CLINICAL NUTRITION, 2024, 43 (04) : 1041 - 1061
  • [9] Berberine in the Treatment of Diabetes Mellitus: A Review
    Baska, Aleksandra
    Leis, Kamil
    Galazka, Przemyslaw
    [J]. ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2021, 21 (08) : 1379 - 1386
  • [10] Systematic review and meta-analysis of vildagliptin for treatment of type 2 diabetes
    Bekiari, Eleni
    Rizava, Chrysoula
    Athanasiadou, Eleni
    Papatheodorou, Konstantinos
    Liakos, Aris
    Karagiannis, Thomas
    Mainou, Maria
    Rika, Maria
    Boura, Panagiota
    Tsapas, Apostolos
    [J]. ENDOCRINE, 2016, 52 (03) : 458 - 480